NEW YORK, April 5, 2017 /PRNewswire/ --
FinancialBuzz.com News Commentary
The legal cannabis market is growing rapidly in the North America. According to Arcview
Market Research, people in the United States and Canada spent
an estimated $53.3 billion on legal cannabis products in 2016. The report shows that the illegal
cannabis market accounted for about 87 percent of the total sales in 2016, down from 90 percent in 2015. The black market is
losing ground to the legal market as more states in the U.S. voted in favor of reforms and legalizing cannabis. Policy makers in
Canada are expected to begin the process of cannabis legalization in the near future.
ChineseInvestors.com Inc. (OTC: CIIX), OWC Pharmaceutical Research Corporation (OTC: OWCP), General Cannabis Corporation (OTC:
CANN), United Cannabis Corporation (OTC: CNAB), Corbus Pharmaceuticals (NASDAQ: CRBP).
According to reports from Canadian national broadcaster, CBC News, the current Liberal government in Canada will announce legislation this month to legalize cannabis in Canada
by July 1, 2018. The new law will allow adults with a minimum age of 18 to purchase cannabis and
grow up to four cannabis plants per household. The report also said that the federal government will be in charge of licensing
producers, while provincial governments will have the right to set price and manage distribution.
ChineseInvestors.com Inc. (OTCQB: CIIX) earlier today announced, "It will attend the 'Invest 2017' exhibition in
Stuttgart, Germany which will take place from April 7th-8th, 2017.
Invest 2017 is the leading trade fair and congress for finance and investment in Germany and
provides CIIX the opportunity to introduce its media and nutritional hemp companies, http://www.ChineseFN.com and http://www.ChineseCBDoil.com to German investors.
Invest 2017 is considered to be the No. 1 meeting point for the finance and investment sector in Germany. As one of the largest financial sector events in Germany, it
attracted more than 12,000 visitors and 144 exhibitors in 2016. Many private and institutional investors use the platform to
obtain information, compare assets and invest while exhibitors have the opportunity to generate interest in raising investment
capital for their ventures."
"I am delighted that CIIX is invited to attend 'Invest 2017' as an exhibitor. This exhibition provides CIIX a valuable
opportunity to introduce our nutritional hemp business to the German financial sector and meet numerous potential investors,"
says Warren Wang, Founder and CEO of CIIX. He further added, "In March
2017, an act to legalize the use of cannabis for medicinal purposes was passed by the German parliament. The recent
approval of medical cannabis will be good for the development of the hemp-based CBD market in Germany."
OWC Pharmaceutical Research Corporation (OTCQB: OWCP) is engaged in the business, through its wholly-owned Israeli
subsidiary, One World Cannabis Ltd., of conducting medical research and clinical trials, in full compliance with all
international regulatory protocols, for the development of cannabis-based products and treatments that target a variety of
diseases and medical indications. The company works to bring patients better outcomes by identifying unique formulation and
efficient delivery systems. The company offers Sublingual Soluble Tablets and Topical Creams. Its Tablets provide patients with
an adequate alternative to smoking cannabis buds for the treatment and management of pain, and its Topical Cream treats various
skin diseases, such as Psoriasis.
General Cannabis Corporation (OTCQB: CANN) is the all-in-one resource for the highest quality service providers
available to the regulated cannabis industry. General Cannabis is a trusted partner to the cultivation, production and retail
sides of the cannabis business through a combination of strong operating divisions such as security, marketing, operational
consulting and products, real estate and financing. As a synergistic holding company, its divisions are able to leverage the
strengths of each other, as well as a larger balance sheet, to succeed. Its subsidiaries include, Chiefton Design, GC Capital,
Next Big Crop, Iron Protection Group, and Chiefton Supply Company.
United Cannabis Corporation (OTCQB: CNAB) provides consulting services, proprietary products and licenses its
intellectual property to businesses in the cannabis industry. United Cannabis own distinct intellectual property relating to the
legalized growth, production, manufacture, marketing, management, utilization and distribution of medical and recreational
marijuana and marijuana infused products. The Company's A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals
provide a comprehensive solution designed to enable physicians and patients to implement and monitor effective therapy protocols.
Prana Bio Nutrient Medicinals is a comprehensive full spectrum cannabinoid system that utilizes the entire cannabis plant by
controlling specific cannabinoid ratios, accurate dosing, and multiple non-abrasive delivery methods.
Corbus Pharmaceuticals (NASDAQ: CRBP) is a clinical stage biopharmaceutical company focusing on rare, life-threatening,
chronic inflammatory diseases. The company's pipeline drug, Anabasum (JBT-101 or Resunab), is a first in class, synthetic oral
endocannabinoid-mimetic drug that preferentially binds to the CB2 receptor expressed on activated immune cells and fibroblasts.
CB2 activation triggers endogenous pathways that resolve inflammation and halt fibrosis. Anabasum has the potential to be a safe
and potent anti-inflammatory drug with a unique mechanism of action to treat a range of chronic inflammatory diseases. Anabasum
is currently being evaluated for the treatment of cystic fibrosis, diffuse cutaneous systemic sclerosis ('systemic sclerosis'),
dermatomyositis and systemic lupus erythematosus, four indications in which inflammation contribute to disease progression.
Please Sign Up Now at http://www.FinancialBuzz.com to receive
alerts on trending financial news from all these companies. 'The Latest Buzz in Financial News'
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
service agreements with the companies which are the subject to the articles posted on the Site or other editorials for
advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions as we purely incorporate public market research along with financial and corporate news.
FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media
platform. We also do not include any personal opinions or commentary. For this release, FinancialBuzz.com expects to be
compensated three thousand dollars for financial news dissemination and PR services by
ChineseInvestors.com Inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on
this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement
and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com has signed a two year agreement with
chineseinvestors.com inc. for one hundred thousand restricted common shares for continued financial news dissemination
and PR services. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news
PR advertising. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information
about any companies the information contained herein is not intended to be used as the basis for investment decisions and should
not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to
buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result
from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes
electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own
independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com, by
accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended
from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase,
hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor.
This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular
security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and
tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions.
We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to
change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not
guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com
For further information:
info@financialbuzz.com
+1-877-601-1879
Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com